IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 31 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,711,000 | -35.4% | 10,000,000 | -33.3% | 0.08% | -48.7% |
| Q1 2019 | $16,570,000 | +13.7% | 15,000,000 | -3.2% | 0.15% | -15.6% |
| Q4 2018 | $14,568,000 | -6.8% | 15,500,000 | +29.2% | 0.18% | +1.1% |
| Q3 2018 | $15,637,000 | -2.1% | 12,000,000 | 0.0% | 0.18% | -27.3% |
| Q2 2018 | $15,974,000 | +12.6% | 12,000,000 | 0.0% | 0.24% | -9.6% |
| Q1 2018 | $14,185,000 | -15.8% | 12,000,000 | -17.2% | 0.27% | -43.1% |
| Q4 2017 | $16,856,000 | -5.8% | 14,500,000 | -3.3% | 0.48% | -24.2% |
| Q3 2017 | $17,896,000 | +33.2% | 15,000,000 | +50.0% | 0.63% | +72.1% |
| Q2 2017 | $13,431,000 | +115.2% | 10,000,000 | +100.0% | 0.36% | +134.0% |
| Q1 2017 | $6,240,000 | +8.6% | 5,000,000 | 0.0% | 0.16% | -12.4% |
| Q4 2016 | $5,746,000 | -4.0% | 5,000,000 | 0.0% | 0.18% | +35.9% |
| Q3 2016 | $5,984,000 | -22.8% | 5,000,000 | -33.3% | 0.13% | -11.5% |
| Q2 2016 | $7,751,000 | – | 7,500,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|